SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/25/20 Exagen Inc. 10-K 12/31/19 88:11M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.33M 2: EX-10.27 Material Contract HTML 29K 3: EX-10.28 Material Contract HTML 33K 4: EX-10.29 Material Contract HTML 53K 5: EX-10.31 Material Contract HTML 32K 6: EX-10.32 Material Contract HTML 87K 7: EX-10.33 Material Contract HTML 269K 8: EX-10.36 Material Contract HTML 59K 9: EX-10.41 Material Contract HTML 28K 10: EX-23.1 Consent of Experts or Counsel HTML 25K 11: EX-31.1 Certification -- §302 - SOA'02 HTML 31K 12: EX-31.2 Certification -- §302 - SOA'02 HTML 31K 13: EX-32.1 Certification -- §906 - SOA'02 HTML 28K 28: R1 Cover HTML 91K 62: R2 Condensed Balance Sheets HTML 98K 85: R3 Unaudited Condensed Statements of Operations HTML 79K 40: R4 Unaudited Condensed Statements of Redeemable HTML 111K Convertible Preferred Stock and Stockholders' Equity 27: R5 Statements of Cash Flows HTML 142K 61: R6 Unaudited Condensed Statements of Redeemable HTML 32K Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) 84: R7 Condensed Balance Sheets - (Parenthetical) HTML 66K 38: R8 Statement of Cash Flows (Parenthetical) HTML 26K 29: R9 Organization - (Notes) HTML 35K 71: R10 Summary Of Significant Accounting Policies - HTML 147K (Notes) 80: R11 Other Financial Information - (Notes) HTML 81K 52: R12 Borrowings - (Notes) HTML 49K 22: R13 Warrants to Purchase Common or Preferred Stock - HTML 45K (Notes) 72: R14 Commitment and Contingencies - (Notes) HTML 52K 81: R15 Fair Value Measurements - (Notes) HTML 65K 53: R16 Redeemable Convertible Preferred Stock HTML 39K 23: R17 Stockholders' Equity (Deficit) HTML 30K 73: R18 Stock Option Plan HTML 87K 79: R19 Income Taxes HTML 102K 42: R20 Related Parties HTML 31K 30: R21 401(k) Plan HTML 27K 58: R22 Subsequent Events HTML 30K 82: R23 Summary Of Significant Accounting Policies - HTML 107K Policies 43: R24 Summary Of Significant Accounting Policies - HTML 119K (Tables) 31: R25 Other Financial Information - (Tables) HTML 84K 59: R26 Borrowings - (Tables) HTML 38K 83: R27 Warrants to Purchase Common or Preferred Stock - HTML 44K (Tables) 41: R28 Commitment and Contingencies (Tables) HTML 65K 32: R29 Fair Value Measures and Disclosures (Tables) HTML 67K 26: R30 Stock Option Plan (Tables) HTML 90K 56: R31 Income Taxes (Tables) HTML 103K 78: R32 Organization - (Details) HTML 51K 70: R33 Summary Of Significant Accounting Policies - HTML 52K Narrative (Details) 25: R34 Summary Of Significant Accounting Policies - HTML 52K Revenue by Major Payers (Details) 54: R35 Summary Of Significant Accounting Policies - HTML 38K Disaggregation of Revenue (Details) 77: R36 Summary Of Significant Accounting Policies - Cash, HTML 35K cash equivalents and restricted cash (Details) 69: R37 Summary Of Significant Accounting Policies - HTML 36K Securities (Details) 24: R38 Other Financial Information - Narrative (Details) HTML 32K 57: R39 Other Financial Information - Prepaid expenses HTML 38K (Details) 36: R40 Other Financial Information - Property and HTML 45K equipment (Details) 45: R41 Other Financial Information - Accrued liabilities HTML 48K (Details) 88: R42 Borrowings - Narrative (Details) HTML 78K 66: R43 Borrowings - Future minimum payments (Details) HTML 49K 34: R44 Warrants to Purchase Common or Preferred Stock - HTML 36K Narrative (Details) 44: R45 Warrants to Purchase Common or Preferred Stock - HTML 40K Outstanding warrants (Details) 87: R46 Commitment and Contingencies - Narrative (Details) HTML 55K 65: R47 Commitment and Contingencies - Minimum annual HTML 69K lease payments under non-cancelable lease arrangements (Details) 33: R48 Fair Value Measurements - Fair value measurement HTML 45K (Details) 46: R49 Fair Value Measurements- Fair value level 3 HTML 42K (Details) 49: R50 Redeemable Convertible Preferred Stock (Details) HTML 83K 19: R51 Stockholders' Equity (Deficit) (Details) HTML 49K 67: R52 Stock Option Plan - Narrative (Details) HTML 71K 74: R53 Stock Option Plan - Stock Option Activity HTML 83K (Details) 51: R54 Stock Option Plan - Fair Value Assumptions HTML 46K (Details) 20: R55 Stock Option Plan - Stock-Based Compensation HTML 34K Expense (Details) 68: R56 Stock Option Plan - Common Stock Reserved For HTML 35K Future Issuance (Details) 75: R57 Income Taxes (Details) HTML 39K 48: R58 Income Taxes - Components of Income Tax Expense HTML 48K (Benefit) (Details) 21: R59 Income Taxes - Reconciliation of Effective Income HTML 47K Tax Rate (Details) 63: R60 Income Taxes - Reconciliation of Deferred Tax HTML 61K Assets and Liabilities (Details) 86: R61 Income Taxes - Change In Valuation Allowance HTML 31K (Details) 47: R62 Related Parties (Details) HTML 45K 37: R63 401(k) Plan (Details) HTML 28K 64: R64 Subsequent Events (Details) HTML 42K 39: R9999 Uncategorized Items - exdx-20191231.htm HTML 25K 55: XML IDEA XML File -- Filing Summary XML 147K 35: XML XBRL Instance -- exdx-20191231_htm XML 1.84M 50: EXCEL IDEA Workbook of Financial Reports XLSX 87K 15: EX-101.CAL XBRL Calculations -- exdx-20191231_cal XML 235K 16: EX-101.DEF XBRL Definitions -- exdx-20191231_def XML 679K 17: EX-101.LAB XBRL Labels -- exdx-20191231_lab XML 1.77M 18: EX-101.PRE XBRL Presentations -- exdx-20191231_pre XML 1.03M 14: EX-101.SCH XBRL Schema -- exdx-20191231 XSD 172K 76: JSON XBRL Instance as JSON Data -- MetaLinks 364± 562K 60: ZIP XBRL Zipped Folder -- 0001274737-20-000026-xbrl Zip 733K
|
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/25/20 | 8-K | ||
For Period end: | 12/31/19 | |||
7/12/19 | ||||
12/31/18 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/18/24 Exagen Inc. 10-K 12/31/23 76:8.9M 5/04/23 Exagen Inc. 8-K:1,2,9 4/28/23 11:241K 3/20/23 Exagen Inc. 10-K 12/31/22 76:9.1M 3/22/22 Exagen Inc. 10-K 12/31/21 73:8.6M Workiva Inc Wde… FA01/FA 4/01/21 Exagen Inc. 10-K/A 12/31/20 14:498K 3/23/21 Exagen Inc. 424B5 1:601K Donnelley … Solutions/FA 3/22/21 Exagen Inc. 424B5 1:599K Donnelley … Solutions/FA 3/16/21 Exagen Inc. 10-K 12/31/20 78:8.7M |